Fenodex 25 mg film-coated tablets EFG
Spain
Table of Contents
- Package leaflet: Information for the user
- Introduction
- **Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you.**
- **Package leaflet**
- 1. What Fenodex is and what it is used for
- 2. What you need to know before taking Fenodex
- 3. How to take Fenodex
- **Use in children and adolescents**
- **If you take more Fenodex than you should**
- **If you forget to take Fenodex**
- 4. Possible adverse effects
- 5. Storage of Fenodex
- 6. Contents of the pack and other information
Package leaflet: Information for the user
Introduction
Package leaflet: information for the user
Fenodex 12.5 mg film-coated tablets EFG
Fenodex 25 mg film-coated tablets EFG
dexketoprofen
Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you.
- Keep this leaflet, as you may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only, and you should not give it to others, even if they have the same symptoms as you, because it may harm them.
- If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.
Package leaflet
- What Fenodex is and what it is used for.
- What you need to know before taking Fenodex.
- How to take Fenodex.
- Possible side effects.
- How to store Fenodex.
- Contents of the pack and other information.
1. What Fenodex is and what it is used for
Fenodex contains dexketoprofen, which is an analgesic belonging to a group of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs).
It is used in adults to treat mild to moderate pain, such as muscle pain, painful menstruation (dysmenorrhea), and dental pain.
You should consult a doctor if your condition worsens or does not improve after 3-4 days.
2. What you need to know before taking Fenodex
Do not take Fenodex
- If you are allergic to dexketoprofen trometamol or to any of the other components of this medicine (listed in section 6);
- If you are allergic to acetylsalicylic acid or to another non-steroidal anti-inflammatory drug (NSAID);
- If you have asthma or have experienced asthma attacks, acute allergic rhinitis (a short period of inflammation of the nasal mucosa), nasal polyps (fleshy growths inside the nose due to allergy), urticaria (skin rash), angioedema (swelling of the face, eyes, lips, or tongue, or difficulty breathing), or wheezing in the chest after taking acetylsalicylic acid or other NSAIDs;
- If you have previously experienced photoallergic or phototoxic reactions (a special type of redness or sunburn-like skin damage on sun-exposed skin) while taking ketoprofen (a non-steroidal anti-inflammatory drug) or fibrates (medicines used to reduce blood fat levels);
- If you have peptic ulcer, gastrointestinal bleeding, or have previously experienced gastrointestinal bleeding, ulceration, or perforation;
- If you have chronic digestive problems (e.g., indigestion, heartburn);
- If you have previously experienced gastrointestinal bleeding or perforation due to prior use of NSAIDs taken for pain;
- If you have chronic inflammatory bowel disease (Crohn’s disease or ulcerative colitis);
- If you have severe heart failure, moderate to severe renal failure, or severe hepatic failure;
- If you have bleeding disorders or blood coagulation disorders;
- If you are severely dehydrated (have lost a large amount of body fluid) due to vomiting, diarrhea, or insufficient fluid intake;
- If you are in the third trimester of pregnancy or breastfeeding;
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine:
- If you are allergic or have previously had allergic problems;
- If you have kidney, liver, or heart disease (hypertension and/or heart failure), fluid retention, or have previously had any of these conditions;
- If you are taking diuretics or have inadequate hydration and reduced blood volume due to excessive fluid loss (e.g., from excessive urination, diarrhea, or vomiting);
- If you have heart disease, a history of stroke, or think you may be at risk of these conditions (e.g., you have high blood pressure, diabetes, high cholesterol, or are a smoker), you should discuss this treatment with your doctor or pharmacist. Medicines like this may be associated with a small increased risk of heart attacks (“myocardial infarction”) or strokes (“cerebrovascular accident”). This risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose or duration of treatment;
- If you are elderly, you may be more likely to experience adverse effects (see section 4).
- If any of these occur, consult your doctor immediately;
- If you are a woman with fertility problems (this medicine may reduce fertility, so you should not take it if you are planning to become pregnant or undergoing fertility investigations);
- If you have a disorder affecting blood or blood cell production;
- If you have systemic lupus erythematosus or mixed connective tissue disease (immune system disorders affecting connective tissue);
- If you currently have or have previously had chronic inflammatory bowel disease (ulcerative colitis, Crohn’s disease);
- If you currently have or have previously had stomach or intestinal disorders;
- If you have an infection; see the section “Infections” below;
- If you are taking other medicines that increase the risk of peptic ulcer or bleeding, for example, oral corticosteroids, certain antidepressants (SSRIs, Selective Serotonin Reuptake Inhibitors), or agents that prevent blood clotting such as acetylsalicylic acid (aspirin) or anticoagulants like warfarin. In such cases, consult your doctor before taking this medicine: your doctor may prescribe an additional medicine to protect your stomach (e.g., misoprostol or other medicines that block gastric acid production).
- If you have asthma, combined with chronic rhinitis or sinusitis, and/or nasal polyps, as you have a higher risk of being allergic to acetylsalicylic acid and/or NSAIDs than the general population. Taking this medicine may trigger asthma attacks or bronchospasm, particularly in patients allergic to acetylsalicylic acid or NSAIDs.
Infections
Dexketoprofen may mask signs of infection such as fever and pain. Therefore, this medicine may delay appropriate treatment of the infection, increasing the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections associated with chickenpox. If you take this medicine while having an infection and infection symptoms persist or worsen, consult a doctor without delay.
During chickenpox, it is advisable to avoid using this medicine.
Kounis Syndrome
Signs of allergic reaction to this medicine, including breathing difficulties, facial and neck swelling (angioedema), and chest pain, have been reported with dexketoprofen.
Stop treatment with dexketoprofen immediately and contact your doctor or emergency services immediately if you experience any of these symptoms.
Children and adolescents
Dexketoprofen has not been studied in children or adolescents. Therefore, safety and efficacy have not been established, and the medicine should not be used in children or adolescents.
Taking Fenodex with other medicines
Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines. Some medicines should not be taken together, while others may require dose adjustments when used concomitantly.
Always inform your doctor, dentist, or pharmacist if, in addition to dexketoprofen, you are taking any of the following medicines:
Combinations not recommended:
- Acetylsalicylic acid, corticosteroids, and other anti-inflammatory drugs;
- Warfarin, heparin, and other medicines used to prevent blood clotting;
- Lithium, used to treat certain mood disorders;
- Methotrexate (a cancer and immunosuppressive medicine), when used at high doses of 15 mg/week;
- Hydantoins and phenytoin, used for epilepsy;
- Sulfamethoxazole, used for bacterial infections;
Combinations requiring caution:
- ACE inhibitors, diuretics, beta-blockers, and angiotensin II antagonists, used for controlling high blood pressure and heart disorders;
- Pentoxifylline and oxpentifylline, used to treat chronic venous ulcers;
- Zidovudine, used to treat viral infections;
- Aminoglycoside antibiotics, used to treat bacterial infections;
- Sulfonylureas (e.g., chlorpropamide and glyburide), used for diabetes;
- Methotrexate, when used at low doses, less than 15 mg/week;
Combinations to be aware of:
- Quinolones (e.g., ciprofloxacin, levofloxacin), used for bacterial infections;
- Cyclosporine or tacrolimus, used to treat immune system disorders and in organ transplantation;
- Streptokinase and other thrombolytic and fibrinolytic medicines; i.e., medicines used to dissolve clots;
- Probenecid, used for gout;
- Digoxin, used in the treatment of chronic heart failure;
- Mifepristone, used as an abortifacient (for termination of pregnancy);
- Antidepressants of the Selective Serotonin Reuptake Inhibitor (SSRI) type;
- Antiplatelet agents used to reduce platelet aggregation and clot formation.
- Beta-blockers, used for high blood pressure and heart disorders
- Tenofovir, deferasirox, pemetrexed.
If you have any doubts about taking other medicines with dexketoprofen, consult your doctor or pharmacist.
Taking Fenodex with food and drinks
Take the tablets with an adequate amount of water. Take the tablets with food, as this helps reduce the risk of gastrointestinal adverse effects. However, in the case of acute pain, take the tablets on an empty stomach; that is, at least 30 minutes before meals, as this allows the medicine to act slightly faster.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medicine, as it may not be suitable for you.
Do not take Fenodex during the last three months of pregnancy, as it may harm the fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your and your baby’s tendency to bleed and may delay or prolong labor more than expected. You should not take Fenodex during the first six months of pregnancy unless clearly necessary and as directed by your doctor. If treatment is needed during this period or while trying to conceive, you should take the lowest effective dose for the shortest possible time. From week 20 of pregnancy, Fenodex may cause kidney problems in your fetus if taken for more than a few days, which may lead to low levels of amniotic fluid surrounding the baby (oligohydramnios). If treatment for longer than a few days is needed, your doctor may recommend additional monitoring.
Women who are planning pregnancy or are pregnant should avoid using this medicine. Treatment at any stage of pregnancy should only occur under a doctor’s guidance.
Use of this medicine is not recommended when trying to conceive or while being evaluated for infertility. Regarding potential effects on female fertility, see also section 2, “Warnings and precautions”.
Driving and using machines
This medicine may slightly affect your ability to drive and use machines, as it may cause drowsiness or dizziness as adverse effects of treatment. If you experience these effects, do not operate machinery or drive until these symptoms resolve. Seek advice from your doctor.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; hence, it is essentially “sodium-free”.
3. How to take Fenodex
Follow exactly the instructions given by your doctor or pharmacist for taking this medicine. If you are unsure, consult your doctor or pharmacist again.
In general, the recommended dose is 1 tablet (25 mg) every 8 hours, without exceeding 3 tablets per day (75 mg).
In general, the recommended dose is 1 tablet (12.5 mg) every 4 to 6 hours, without exceeding 6 tablets per day (75 mg).
Consult your doctor if you do not feel better or feel worse after 3–4 days. Your doctor will advise you on how many tablets you should take each day and for how long. The dose of this medicine you need depends on the type, severity, and duration of your pain.
If you are an elderly patient or have any kidney or liver disease, it is recommended to start therapy with a total daily dose of no more than 2 tablets of 25 mg or 4 tablets of 12.5 mg (50 mg).
In elderly patients, this initial dose may subsequently be increased to the general recommended dose (75 mg), provided this medicine has been well tolerated.
If your pain is severe and you need rapid relief, take the tablets on an empty stomach (at least 30 minutes before food), as they will be absorbed more easily (see section 2 "Taking Fenodex with food and drink").
Use in children and adolescents
This medicine must not be used in children and adolescents (under 18 years of age).
If you take more Fenodex than you should
If you have taken too much medicine, inform your doctor or pharmacist immediately or go to the nearest hospital emergency department. Please remember to always bring the medicine pack or this leaflet with you.
In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately, or call the Toxicology Information Service at telephone number: 91562 04 20, indicating the medication and the amount ingested.
If you forget to take Fenodex
Take the next dose at the scheduled time (according to section 3 "How to take Fenodex"). Do not take a double dose to make up for a missed dose.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine can cause adverse effects, although not everyone will experience them. The possible adverse effects are listed below according to their frequency.
Frequent adverse effects (may affect up to 1 in 10 people):
Nausea and/or vomiting, mainly upper abdominal pain, diarrhoea, digestive disorders (dyspepsia).
Uncommon adverse effects (may affect up to 1 in 100 people):
Spinning sensation (vertigo), dizziness, drowsiness, sleep disturbances, nervousness, headache, palpitations, hot flushes, inflammation of the stomach wall (gastritis), constipation, dry mouth, flatulence, skin rash, fatigue, pain, feeling feverish and chills, general malaise.
Rare adverse effects (may affect up to 1 in 1,000 people):
Peptic ulcer, peptic ulcer perforation or bleeding (which may present as vomiting blood or black stools), fainting, high blood pressure, slow breathing, fluid retention and peripheral swelling (e.g. swollen ankles), laryngeal oedema, loss of appetite (anorexia), abnormal sensation, pruritic rash, acne, increased sweating, lower back pain, frequent urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood tests), liver cell damage (hepatitis), acute kidney failure.
Very rare (may affect up to 1 in 10,000 people):
Anaphylactic reaction (hypersensitivity reaction which may also lead to collapse), skin, mouth, eye or genital ulcers (Stevens-Johnson syndrome and Lyell syndrome), facial swelling or swelling of lips and throat (angioedema), breathing difficulty due to narrowing of the airways (bronchospasm), shortness of breath, tachycardia, low blood pressure, inflammation of the pancreas, blurred vision, ringing in the ears (tinnitus), sensitive skin, photosensitivity, itching, kidney problems. Decreased white blood cell count (neutropenia), decreased platelet count (thrombocytopenia).
Frequency not known (cannot be estimated from the available data)
Chest pain, which may be a sign of a potentially serious allergic reaction called Kounis syndrome.
Drug-induced fixed eruption
Cutaneous allergic reaction known as drug-induced fixed eruption, which may include round or oval-shaped areas of redness and swelling of the skin, blister formation and itching. Skin darkening in the affected areas may also occur, which could persist after healing. Drug-induced fixed eruption usually reappears in the same area(s) if the medicine is taken again.
Immediately inform your doctor if you notice any gastrointestinal adverse effects at the beginning of treatment (e.g. stomach pain or burning sensation or bleeding), especially if you have previously experienced any of these adverse effects due to long-term treatment with anti-inflammatory medicines, and particularly if you are an elderly patient.
Stop taking this medicine immediately if you notice the appearance of a skin rash or any lesions in the mouth or genital area, or any other sign of allergy.
During treatment with non-steroidal anti-inflammatory drugs (NSAIDs), cases of fluid retention and swelling (especially in ankles and legs), increased blood pressure and heart failure have been reported.
Medicines like this one may be associated with a small increased risk of having a heart attack (“myocardial infarction”) or stroke (“cerebrovascular accident”).
In patients with immune system disorders affecting connective tissue (systemic lupus erythematosus or mixed connective tissue disease), anti-inflammatory medicines may rarely cause fever, headache and neck stiffness.
The most commonly observed adverse effects are gastrointestinal. Peptic ulcers, gastrointestinal perforation or bleeding, sometimes fatal, may occur, particularly in elderly patients. After administration, nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, and worsening of colitis and Crohn’s disease have been reported. Less frequently, inflammation of the stomach wall (gastritis) has been observed.
As with other NSAIDs, haematological reactions may occur (purpura, aplastic and haemolytic anaemia, and more rarely agranulocytosis and medullary hypoplasia).
Reporting of adverse effects
If you experience any adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Fenodex
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.
Do not store above 30°C. Store in the original packaging to protect from light and moisture.
Medicines must not be disposed of via wastewater drains or household waste. Unused medicines and their packaging should be returned to the SIGRE Point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of medicines and packaging you no longer need. This will help protect the environment.
6. Contents of the pack and other information
Composition of Fenodex
- The active substance is dexketoprofen trometamol. Each tablet contains 12.5 mg or 25 mg of dexketoprofen as dexketoprofen trometamol.
- The other components are: microcrystalline cellulose PH101, microcrystalline cellulose PH102, sodium carboxymethyl starch (from potato) (type A), corn starch, glycerol distearate (type 1), white Opadry 03G280003 (macrogol, titanium dioxide, propylene glycol, hypromellose), yellow iron oxide (only in the 12.5 mg dose).
Appearance of the product and contents of the pack
Fenodex 12.5 mg film-coated tablets are yellow, round, biconvex tablets with a diameter of 7 mm.
Fenodex 25 mg film-coated tablets are white, round, biconvex, scored tablets with the inscription "MC" in relief and a diameter of 10 mm.
The 25 mg tablets can be divided into equal doses.
Fenodex 12.5 mg: Available in boxes of 10, 20, 30, 40, 50 or 500 tablets in PVC/PVDC/Aluminium blisters.
Fenodex 25 mg: Available in boxes of 4, 10, 20, 30, 50 or 500 tablets in PVC/PVDC/Aluminium blisters.
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer:
Marketing Authorization Holder:
Medochemie Limited
1-10 Constantinoupoleos Street
3011 Limassol
Cyprus
Manufacturer responsible:
Medochemie Ltd. (Central Factory),
1-10 Konstantinoupoleos street,
3011 Limassol,
Cyprus
You can request further information about this medicinal product from the local representative of the marketing authorization holder:
Local representative:
Medochemie Iberia S.A., Sucursal en España
Avenida de las Águilas, nº 2 B; planta 5 oficina 6,
28044 Madrid
SPAIN
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Country | Name of the medicinal product |
Latvia | Fenodex 25 mg coated tablets |
Cyprus | Fenodex 12.5 mg, 25 mg film-coated tablets |
Bulgaria | Fenodex 12.5 mg, 25 mg coated tablets |
Estonia | Fenodex |
Spain | Fenodex 12.5 mg, 25 mg film-coated tablets |
Malta | Fenodex 12.5 mg, 25 mg film-coated tablets |
Lithuania | Fenodex 25 mg film-coated tablets |
Date of the last revision of this leaflet: November 2025
Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/